Tag: the-treatment
-
Drug resistance in people and animals may push millions into poverty: World Bank
By Alex Whiting ROME (Thomson Reuters Foundation) – If drug-resistant infections in people and animals are allowed to spread unchecked, some 28 million people will fall into poverty by 2050, and a century of progress in health will be reversed, the World Bank said on Monday. By 2050, annual global GDP would fall by at least…
-
Australian PM orders inquiry after teenage prisoners teargassed, stripped naked
By Matt Siegel and Tom Westbrook SYDNEY (Reuters) – Australian Prime Minister Malcolm Turnbull on Tuesday ordered an inquiry into the treatment of children in detention after the airing of video showing prison guards teargassing teenage inmates and strapping a half-naked, hooded-boy to a chair. Footage of the abuse of six aboriginal boys in a…
-
Australian PM orders inquiry after teenage prisoners teargassed, stripped naked
By Matt Siegel and Tom Westbrook SYDNEY (Reuters) – Australian Prime Minister Malcolm Turnbull on Tuesday ordered an inquiry into the treatment of children in detention after the airing of video showing prison guards teargassing teenage inmates and strapping a half-naked, hooded-boy to a chair. Footage of the abuse of six aboriginal boys in a…
-
Knife attacker in Japan kills 19 in their sleep at disabled center
By Elaine Lies and Kwiyeon Ha SAGAMIHARA, Japan (Reuters) – A knife-wielding man broke into a facility for the disabled in a small town near Tokyo early on Tuesday and killed 19 patients as they slept, authorities said, Japan's worst mass killing in decades. At least 25 other residents were wounded in the attack at…
-
Sanofi and Regeneron report positive skin disease trial
French drugmaker Sanofi SA and U.S. partner Regeneron Pharmaceuticals Inc said a one-year, late-stage study of dupilumab, a monoclonal antibody designed for the treatment of skin diseases, had met its main goals. “These are the first long-term Phase 3 data that demonstrated dupilumab with topical corticosteroids was superior to topical corticosteroids alone, and provided sustained…
-
Sanofi and Regeneron report positive skin disease trial
French drugmaker Sanofi SA and U.S. partner Regeneron Pharmaceuticals Inc said a one-year, late-stage study of dupilumab, a monoclonal antibody designed for the treatment of skin diseases, had met its main goals. “These are the first long-term Phase 3 data that demonstrated dupilumab with topical corticosteroids was superior to topical corticosteroids alone, and provided sustained…
-
China issues corruption warning after training center visits
China’s top graft buster followed up a series of inspections of elite sports training centers by reiterating its warning against corruption in the run-up to the Rio Olympics on Monday. The Beijing Sport University and the Olympic Training center were among departments visited by inspectors attached to the sports ministry, the ruling Communist Party’s Central…
-
Sophiris’s prostate drug meets main goal in late-stage study
(Reuters) – Sophiris Bio Inc said on Tuesday its sole drug in development met the main goal of a late stage study, reviving hopes for approval 11 months after the company’s interim analysis suggested the treatment would fail the study. The company said the drug, PRX302, had significantly improved symptoms in men suffering from benign…